Your browser doesn't support javascript.
loading
Germline pathogenic variants in neuroblastoma patients are enriched in BARD1 and predict worse survival.
Kim, Jung; Vaksman, Zalman; Egolf, Laura E; Kaufman, Rebecca; Evans, J Perry; Conkrite, Karina L; Danesh, Arnavaz; Lopez, Gonzalo; Randall, Michael P; Dent, Maiah H; Farra, Lance M; Menghani, Neil L; Dymek, Malwina; Desai, Heena; Hausler, Ryan; Hicks, Belynda; Auvil, Jaime Guidry; Gerhard, Daniela S; Hakonarson, Hakon; Maxwell, Kara N; Cole, Kristina A; Pugh, Trevor J; Bosse, Kristopher R; Khan, Javed; Wei, Jun S; Maris, John M; Stewart, Douglas R; Diskin, Sharon J.
Afiliación
  • Kim J; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.
  • Vaksman Z; Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Egolf LE; Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Kaufman R; Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Evans JP; Cell and Molecular Biology Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Conkrite KL; Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Danesh A; Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Lopez G; Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Randall MP; Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Dent MH; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, ON, Canada.
  • Farra LM; Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Menghani NL; Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Dymek M; Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Desai H; Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Hausler R; Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Hicks B; Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Auvil JG; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Gerhard DS; Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Hakonarson H; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Maxwell KN; Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Cole KA; Cancer Genome Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Pugh TJ; Office of Cancer Genomics, National Cancer Institute, Bethesda, MD, USA.
  • Bosse KR; Office of Cancer Genomics, National Cancer Institute, Bethesda, MD, USA.
  • Khan J; Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Wei JS; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Maris JM; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Stewart DR; Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Diskin SJ; Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
J Natl Cancer Inst ; 116(1): 149-159, 2024 01 10.
Article en En | MEDLINE | ID: mdl-37688579

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Predisposición Genética a la Enfermedad / Neuroblastoma Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Child / Humans Idioma: En Revista: J Natl Cancer Inst Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Predisposición Genética a la Enfermedad / Neuroblastoma Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Child / Humans Idioma: En Revista: J Natl Cancer Inst Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos